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Human chromosome 21 transcriptsWhen applied to complex transcript datasets, current tools for automated assembly of mRNA sequences
require long run times and produce exponentially increasing numbers of splice variants. Here, we describe
RCDA, a genome-based transcript assembly tool comprising RCluster, that recursively clusters transcripts,
and DAssemble, that generates composite transcript sequences through path-ﬁnding using a directed acyclic
graph. Each exon included in a ﬁnal transcript is associated with an array of all upstream consecutive exon
structures obtained from original transcripts. When a depth-ﬁrst-search path reaches an exon, the path is
retained only if it contains a structure from that exon's array. RCDA assemblies, therefore, include only those
transcripts with experimentally supported exon patterns. When applied to >23,000 transcripts from human
chromosome 21, using biologically reasonable ﬁlters, RCDA execution time was approximately 4 h. RCDA
outperformed ECgene in reconstructing RefSeq transcripts and in limiting the total number of transcripts and
transcripts per gene.
© 2012 Elsevier Inc. All rights reserved.1. Introduction
Alternative splicing is a common phenomenon in eukaryotes that
allows multi-exon genes to generate multiple mRNA transcripts
through different exon assemblies. These different mRNA transcripts
from one gene can encode different protein isoforms and/or functional
RNAs. In humans, ~95% of multiexonic genes, comprising 60% to 75% of
all human genes, are alternatively spliced [1–4]. Abnormal splicing
variations are implicated in disease, and a signiﬁcant proportion of
human genetic disorders result from splicing errors [5]. For human and
many other mammalian organisms, the Expressed Sequence Tag
database (dbEST) [6] is a rich resource for identifying alternatively
spliced transcripts. However, the large number of dbEST entries poses a
challenge for developing efﬁcient computational tools to generate
alternatively spliced transcript assemblies.
Prior to the availability of complete genome sequences, transcript
assembly tools, such as STACK-PACK, TGICL, the UniGene clustering tool
and EGassembler [7–10], were based on sequence similarities. There are
also several de novo assemblers [11–15], some of which are more
suitable for usewith short (250–450 nucleotide) reads [16]. A drawbackLinda Crnic Institute for Down
h Ave, Mail Stop 8608, Aurora,
H. Sturgeon),
rights reserved.to these transcript similarity-based tools is that they do not discriminate
chimeric transcripts. Now that high quality genomic sequences are
available for many organisms, popular tools, such as ECgene, ESTgenes,
ASTD, AceView, PASA, SpliceNest, and tools developed by Wong et al.,
Xing et al. and Bonizzoni et al. [17–25], cluster and assemble transcripts
based on genomic coordinates of exons. Such genome-mapped
transcript approaches can eliminate chimeric sequences and result in
fewer splicing artifacts.
In general, genome-based transcript assembly tools ﬁrst cluster
input transcripts and then assemble composite transcripts. In the
clustering step, transcripts with overlapping splice sites or exons are
clustered into groups, each group essentially representing a single
gene. In the assembly step, composite transcripts are assembled from
cluster components, generating a set of “complete” mRNA sequences
representing all splice variants for the gene. Some recently developed
tools, such as EasyCluster, EST2uni, ESTpass and ESTExplorer [26–29],
use only the ﬁrst step, clustering transcripts by mapping to their
genome coordinates.
At the assembly step, a graph-based approach is commonly used.
There are two types of graphs: a spliced graph, such as used in ECgene
[17] and a transcript/EST nodes graph, such as used in ESTgenes and
the assembly tools developed by Xing et al., Wong et al., and
Bonizzoni et al. [18,22–24]. The ECgene spliced graph generates
transcript assemblies through Depth-First-Search (DFS) path-ﬁnding.
With each node representing an exon, such graphs are straightfor-
ward to build and all possible paths can theoretically be found.
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structure within a transcript is lost. The graph does not capture the
transcript compatibility information and may connect together exons
of different, mutually exclusive, splicing structures to create artiﬁcial
patterns that lack biological relevance [22,30,31]. This can also result
in exponentially large numbers of transcripts for single genes and
require enormous amounts of processing time. In addition, it is difﬁcult,
if not impossible, to identify those alternatively spliced transcripts that
are experimentally supported. In contrast, in transcript node graph
tools, such as ESTgenes [18] and ATP [24], each node represents one
transcript; these rely on the factorization of ESTs into constitutive exons
and, therefore, the assembled exon patterns aremore restricted and are
supported by actual transcripts. However, graph constructions are
complicated by connections among transcripts that share subsets of
exons or that have commonmissing or skipped exons [24]. While these
methods can reliably assemble splice variants for transcripts with
simple exon structures, computational time becomes excessive for large
transcript sets with complex alternative splicing.
Here, we introduce a new genome-based transcript clustering and
assembly tool, RCDA. RCDA uses comprehensive clustering followed by
graph-based spliced variant transcript assembly. To control assembly
size, each exon in the RCDA spliced graph contains all of its upstream
consecutive exon structures, which are retrieved from actual
transcripts. Therefore, RCDA restricts the assemblies to those
transcripts with experimentally conﬁrmed exon structures. The
RCDA software, human chromosome 21 (Hsa21) transcript dataset,
and other relevant information are available at http://gfuncpathdb.
ucdenver.edu/iddrc/chr21/HSA21qGene_software.php.
2. Results
2.1. Overview of RCDA
The RCDA algorithm is composed of two components: (1) RCluster
(Recursive Cluster), which comprehensively clusters transcripts into
groups according to genomic order and their overlapping exons and
shared splice sites, and (2) DAssemble, which ﬁrst processes the
transcripts in each group to obtain a unique exon list, generates a
spliced Directed Acyclic Graph (DAG), and then through DFS path
ﬁnding in DAG, forms a comprehensive alternatively spliced transcript
assembly for each cluster.
2.1.1. RCluster
In RCluster, transcripts are ﬁrst sorted based on their chromosomal
genomic start position in ascending order (from short-arm telomere to
long-arm telomere). The run time for RCluster should theoretically
increase exponentially with the number of transcripts to be clustered.
However, by using a sorted transcript list (Section 4.1.1) and because of
the shrinking size of the unclustered set, the run time is closer to O(n),
where n is the number of transcripts. Fig. 1 shows clustering of
transcripts that lack direct overlaps.
2.1.2. DAssemble
The second module of RCDA, DAssemble (DFS-path-ﬁnding
Assemble) is composed of three steps: transcript processing, exonFig. 1. Clustering of transcripts with exons that overlap either in a tiled manner or by
sharing a splice site. Transcript t1 is not directly connected to transcripts t3 and t4,
however, these transcripts are clustered by DAssemble.DAG construction, and assembly via DFS path-ﬁnding. The transcript-
processing step mainly extends the truncated terminal exons to
generate a non-redundant exon list. The cDNA sequences of the
terminal exons of a transcript are often incomplete and can start from
any nucleotide within the ﬁrst exon and terminate at any nucleotide
within the terminal exon. To build a DAG with a unique list of exon
vertices, the truncated terminal exons are extended based on the
existence of longer terminal exons or longer complete internal exons
that share one splice site of the truncated terminal exon (Fig. 2). In
DAG, for each ﬁnal and internal exon of each transcript, the exon node
contains an array of its upstream consecutive exon structures derived
from actual transcripts. DAssemble uses a DFS path-ﬁnding algorithm
to generate composite splice variant sequences for a gene whose exon
structure pattern is veriﬁable in actual transcripts. The path-ﬁndings
start with initial exons and end with ﬁnal exons. As a path reaches an
exon, the upstream path is checked to see if it ends with a pattern
found in that exon's structure array. If so, the path-ﬁnding continues,
otherwise the path is rejected. Thus, RCDA only generates experimentally
supported transcript assemblies, and the time complexity of DAssemble is
closer to O(n3). Fig. 3 shows a spliced DAG and upstream consecutive
exon structure array for each exon.
2.2. RCDA performance
2.2.1. Clustering
We ﬁrst compared the performance of the RCDA clustering module,
RCluster, with that of EasyCluster [26] using a set of 21,599 transcripts
from HSA21 (EasyCluster transcript input, see Section 4.2.2). RCDA
generated 379 clusters, while EasyCluster produced 389. The modest
difference is due to RCDA requiring cluster members to have exon
overlap and EasyCluster requiring a shared splice site. To compare run
times, RCDA and EasyCluster were run under the Linux environment.
After the 45 min required to generate genomic coordinates with GMAP,
RCluster required approximately 48 min to cluster the HSA21q
transcripts, while EasyCluster required approximately 90 min. Thus,
while the run times of bothmethods are acceptable, and RCluster is only
modestly faster, because it features a sorted transcript array andFig. 2. Three rules for extending terminal exons for transcripts mapping to chromosomal
long-arms.
Fig. 3. Upstream structure pattern arrays in DAG exon nodes. When the upstream path
a–b–d–e reaches exon node f, this path ends with b–d–e, which is contained in the
upstream consecutive exon structure array of exon f. The path a–b–d–e–f is therefore
included in the assembly. When the upstream path a–c–e reaches exon node f, the
structure array of exon f does not include a–c–e. Therefore, a–c–e–f is excluded from
the ﬁnal transcript assembly and a–c–e–g is retained. A) Exon patterns in input
transcripts; B) exon arrays as DAG nodes.
Table 1
RCDA and ECgene performance in assembly of HSA21q transcripts.
Program Assemblya Settingsb RefSeqc Sensitivityd Totale Maximumf
RCDAg NCSSN set
at transcript
level
ESN=2 340 77% 4230 1120
NCSSN=0 432 98% 2512 112
NCSSN=0
OSIZE=243
400 90% 2255 103
NCSSN set
at path
ﬁnding level
NCSSN=0 410 93% 2099 76
NCSSN=0
OSIZE=243
378 85% 1883 65
ECgeneh Part A 239 55% 2450 48
Part A+B 251 58% 4272 147
Part
A+B+C
256 59% 11,041 381
a Assembly, transcripts with non-consensus splice sites were eliminated either at
the transcript level prior to path ﬁnding, or during path ﬁnding.
b Settings: ESN, exon support number; NCSSN, number of non-consensus splice sites
allowed within a transcript; OSIZE, length of open reading frame (in nucleotides); Part
A, B and C, transcripts with high, medium and low experimental support [17].
c RefSeq, number of RefSeq transcripts correctly assembled, from 443 and 434
transcripts in the RCDA and ECgene datasets, respectively.
d Sensitivity, % of RefSeq transcripts correctly assembled.
e Total number of assembled transcripts.
f Maximum number of splice variants assembled for a single gene.
g Transcript dataset and genomic coordinates from hg19.
h Transcript dataset and genomic coordinates from hg18.
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method. The use of RCluster also allows the smooth integration of the
clustering process with the assembly process carried out by DAssemble
(see Section 2.2.2). Lastly, another advantage of RCluster over
EasyCluster is that, in RCluster, the recursive clustering of transcripts
that do not directly overlap allows the efﬁcient grouping even of
short transcript sequences. Thus, RCluster will be able to handle the
output of Next Generation Sequencing technologies without
modiﬁcation.
2.2.2. Transcript assembly
We next tested the performance of both RCDA modules, RCluster
plus DAssemble in clustering and assembling the complete set of
23,286 HSA21 transcripts (Section 4.2.1). The initial implementation
of the program was terminated after 72 h when execution was still
incomplete and the largest cluster contained more than 100,000
alternatively spliced transcripts. To decrease the run time and control
the total number of transcripts generated for individual genes, we
added optional settings for two biologically reasonable restrictions.
The ﬁrst option speciﬁes a minimum level of experimental support
for each exon (ESN); ESN requires each exon to be present in the
user-speciﬁed number of input transcripts (default ESN=1). The
second option, NCSSN, speciﬁes the number of non-consensus splice
sites (NCSS), deﬁned as any splice site other than GT-AG, GC-AG or
AT-AC, allowed within a transcript. NCSSN restriction can be applied
at two places in the algorithm, after clustering (transcript level) or
during assembly (path ﬁnding level). If the number of NCSSs exceeds
the user-speciﬁed limit, the transcript is eliminated from the
assembly (default NCSSN=2 and all transcripts with more than 2NCSS are eliminated). With the use of either ESN=2 (with the
default, NCSSN=2) or NCSSN=0 (with the default, ESN=1), RCDA
produced a complete assembly of >23,000 transcripts in less than
4 h. In contrast, with NCSSN=1 (and ESN=1), the run time
exceeded 24 h.
To assess the accuracy of RCDA assemblies, we used the HSA21
RefSeqmRNA sequences as a benchmark because they constitute a set
of expert reviewed and validated transcripts. The test set was
composed of all ESTs and mRNAs mapped to HSA21. A RefSeq
transcript was considered to be correctly assembled if all its exons
were totally and consecutively included in at least one assembled
transcript [32]. As shown in Table 1, with ESN=2, the sensitivity of
RCDA was 77%, i.e. 340 of 443 HSA21 RefSeq transcripts were
assembled correctly. In contrast, withNCSSN=0 at the transcript level,
the sensitivity was 98% (note that speciﬁcity is not included in Table 1
because true negatives are not available for transcript contigs). Thus,
while requiring greater experimental support for each exon (ESN=2
comparedwith the default ESN=1) substantially decreased run time as
discussed above, transcripts with non-consensus splice sites apparently
are a more signiﬁcant source of artifacts in assembly, at least of RefSeq
transcripts.
With NCSSN=0 at the path ﬁnding level, 93% of RefSeq mRNAs
were correctly assembled, a slight decrease from the accuracy at the
transcript level. This occurs when there is a path that extends the 3′
terminal exon of a RefSeq transcript to a downstream exon that lacks
a consensus splice site. In this instance, the number of NCSSs then is
greater than 0 and the path including the RefSeq structure is eliminated
from theﬁnal assembly. At the transcript level, the transcript containing
the extension to a NCSS would have been eliminated prior to assembly.
When applied to the entire HSA21 transcript dataset, these same
settings (NCSSN=0 and, to a lesser extent, ESN=2) also effectively
controlled both the maximum number of transcripts per gene and the
total number of assembled transcripts (Table 1). When RefSeq
transcripts were optimally assembled (NCSSN=0, transcript level),
RCDA generated a total of 2512 transcripts, with a maximum for a
single gene of 112. Combining ESN and NCSSN restrictions did not
improve performance (data not shown).
A third user option allows restricting the length of the open
reading frame (ORF). Combined with NCSSN=0, requiring ORFs of
≥80 amino acids (OSIZE=240) reduced the number of accurately
assembled RefSeq mRNAs to 400 and 378, at the transcript and path
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elimination of short ORFS, some of which have been annotated in
RefSeq as putative non-coding RNAs.
2.3. RCDA outperforms ECgene in assembly of HSA21 transcripts
We compared the performance of RCDA with that of ECgene [17].
Other tools eitherwere unavailable or unable to handle a dataset as large
as the >23,000 transcripts in the HSA21 complete dataset (see
discussion in [26]). The dataset used as ECgene input included the
HSA21 transcripts from the GRC36/hg18 (3/2006), while that used with
RCDA was from GRC37/hg19 (12/2010). Table 1 includes results
obtained with ECgene for the three performance measures: the number
of correctly assembled RefSeq mRNAs, the total number of transcripts
assembled, and the maximum number of transcripts assembled for a
single gene. In contrast to RCDA, ECgene correctly assembled only 55%–
59% of RefSeq mRNAs, for all three run options. The total number of
assembled transcripts also differed signiﬁcantly between the two tools.
With the optimal setting (NCSSN=0, transcript level) for assembly of
RefSeq mRNAs, RCDA generated 2512 transcripts in total from the
>23,000 HSA21 transcripts, while the best performance of ECgene
produced 11,041 transcripts in total. Together, these results suggest that
ECgene is separating single transcripts into multiple non-overlapping
transcripts. As a last comparison, with settings for optimal RefSeq
assembly, RCDA produced a maximum of 112 transcripts for a single
gene while ECgene produced 381.
Recently, Pirola et al. [33] described a new method, PIntron, and
demonstrated its effectiveness for determining genomic structure
and assembly of splice variants for large (>1 Mb) genes associated
with large (20,000) numbers of ESTs. We were unable to test the
performance of PIntron on the complete HSA21 dataset because the
memory requirements for our input of 30 Mb of genomic sequence
exceeded 10 GB. Therefore, while PIntron functioned effectively on
individual genes, RCDA is capable of handling chromosome-sized
genomic sequence.
3. Discussion
RCDA is a genome-based transcript clustering and alternatively
spliced transcript assembly tool. It uses comprehensive recursive
clustering followed by a spliced DAG-based transcript-assembly
method. The spliced graph in the RCDA DAssemble module is
constructed in a straightforward manner and the DFS path ﬁnding
in the spliced graph provides thorough exon structure patterns for
generating transcript assemblies. Each exon in the RCDA graph
preserves an array of all its upstream consecutive exon structures
retrieved from actual transcripts. As path ﬁnding reaches an exon, if
the upstream path exon structure ends with a pattern in that exon's
structure array, then the path ﬁnding continues, otherwise the path is
rejected. Using this technique, RCDA effectively restricts the assembly
size and retains in assembled transcripts only those with exon
structures present in actual transcripts.
RCDA provides the user with options to restrict the number of non-
consensus splice sites and/or to require a minimum experimental
support for individual exons. Use of these options results in efﬁcient run
times and controls the total numbers of alternatively spliced products.
These are also biologically reasonable restrictions, helping to eliminate
sequencing and cDNA library artifacts. Results of RefSeq mRNA
reconstruction with ESN=2 (77% sensitivity) imply that >20% of
RefSeq mRNAs are rare in transcript databases (so that minimum exon
support number is one) or that they have cluster members containing
sequencing errors, particularly in spliced ESTs, that result in poor
alignment to genomic DNA with subsequent misidentiﬁcation of splice
sites and failure to cluster transcripts correctly. Use of NCSSN=0, by
eliminating all input transcripts with non-consensus splice sites, results
in up to 98% sensitivity in assembly of RefSeq transcripts. The 2% ofRefSeq transcripts that were eliminated included one pseudogene,
several putative non-coding mRNAs and two classical protein coding
genes, DONSON and UMODL1. DONSON was eliminated due to a
complex organization of rare spliced ESTs that directly linked DONSON
to the upstream RefSeq mRNA for the CRYZL1 gene. The UMODL1
RefSeq was eliminated due to the presence of a single non-consensus
splice site.
Because RCDA requires contigs to include initial and ﬁnal exons
derived from the original transcript group, there are small differences in
assembly when the allowed number of non-consensus splice sites is set
at the transcript level vs. the path ﬁnding level. However, the overall
success in assembling RefSeq mRNAs supports the reliability of RCDA
results for assembling the complete HSA21 dataset containing >23,000
transcripts. It suggests that numbers for both the total transcripts
assembled and the maximum transcripts per gene are likely to be
substantially correct. RCDA outperformed ECgene in all three of these
measures. Given the reasonable execution time (approximately 4 h for
the total HSA21 transcript assembly), RCDA provides an efﬁcient and
effective tool for assembling “complete” mRNA sequences from large
transcript datasets with complex alternative splicing patterns. Because
it requires only that the transcript nucleotide sequences are sufﬁciently
accurate for mapping to DNAwith splice site detection, RCDA should be
suitable for use with next generation sequencing data, such as RNAseq.
This will be tested in future applications.
4. Material and methods
4.1. RCDA pseudocode
4.1.1. RCluster pseudocode
In RCluster, transcripts are ﬁrst sorted based on their chromosomal
genomic start position in ascending order (from short-arm telomere to
long-arm telomere). Sorting is critical for reducing the time required for
recursive clustering of all transcripts that directly or indirectly overlap
with each other. The pseudocode for RCluster is as follows:
RCluster pseudocode:
1. Ltranscripts←a set of sorted transcripts to be clustered
2. G←an array for storing groups
3. gn←0
4. while Ltranscripts is not empty do
5. x←head [Ltranscripts]
6. add x to G [gn]
7. delete x from Ltranscripts
8. recursive_cluster (x, G [gn], Ltranscripts)
9. gn←gn+1
recursive_cluster (x, g, Ltranscripts)
1. gendx←x genomic end
2. while Ltranscripts is not empty; do
3. y←head [Ltranscripts]
4. gstarty←y genomic start
5. if gstartybgendx; do
6. if y overlaps with x then
7. add y to g
8. delete y from Ltranscripts
9. recursive_cluster (y, g, Ltranscripts)
10. else
11. break while loop;
The RCluster recursive function, recursive_cluster, uses the follow-
ing input: an initial transcript x, the group g that contains x, and the list
of transcripts Ltranscripts that have not yet been clustered into any group.
The recursive_cluster function returns the group gwith transcript x and
the transcripts that x is associated with, and the new Ltranscriptswith the
remaining transcripts. By the use of this sorted transcript list and
because of the shrinking size of Ltranscripts via transcript clustering, the
361X.H. Sturgeon, K.J. Gardiner / Genomics 100 (2012) 357–362run time for RCluster is close to O(n), where n is the number of
transcripts.
4.1.2. DAssemble pseudocode
The second module of RCDA, DAssemble (DFS-path-ﬁnding
Assemble) is composed of three steps: transcript processing, exon
DAG construction, and the actual assembly step via DFS path-ﬁnding.
The transcript-processing step mainly extends the truncated terminal
exons to generate a non-redundant exon list. Because the terminal
exons of a transcript are often incomplete, to build a DAGwith a unique
list of exon vertices, terminal exons are extended based on the existence
of longer terminal exons or longer complete internal exons that share
one splice site of the truncated terminal exon.
With the chromosome sequence oriented from the short-arm
telomere to the long-arm telomere, the following are the terminal
long-arm exon extension rules (similar rules are applied to terminal
short-arm exons):
1. the 3′ end of the transcripts with a polyA tail (≥9 consecutive
terminal As) or with a polyadenylation signal is not extended
2. if exon e1 (the 3′ terminal exon in transcript t1) overlaps with
exon e2 (a complete internal exon of transcript t2), then e1 is
extended to all of e2 (Fig. 2A)
3. if the situations described in 1and 2 do not occur and exon e1 (the
3′ terminal exon in transcript t1) partially overlaps with exon e2
(the 5′ terminal exon of transcript t2), then the two exons are
merged into a single extended exon (Fig. 2B)
4. if the situations in 1, 2, and 3 do not occur and exon e1 (the 3′
terminal exon in transcript t1) shares one splice site with exon e2
(the 3′ terminal exon of transcript t2), and exon e1 is shorter than
exon e2, then the exons are merged into a single extended exon
(Fig. 2C).
In the next step, DAssemble generates a spliced DAG with a list of
unique exon vertices derived from the previous step and exon–exon
connections edge-directed from the short-arm to the long-arm. The
edges are either consensus spliced sites [34] or non-consensus spliced
sites (NCSS).
In DAG, there are three types of exons: initial exons that have no
upstream exons, ﬁnal exons that have no downstream exons, and
internal exons. For each ﬁnal and internal exon, the exon node contains
an array of its upstream consecutive exon structures derived from
actual transcripts. By maintaining this pattern array, DAssemble rejects
any assembled transcriptwhose exon pattern does not exist in an actual
transcript, and thus only generates experimentally supported transcript
assemblies.
DAssemble uses a DFS path-ﬁnding algorithm that starts with initial
exons and ends with ﬁnal exons. Once a path reaches an exon, the
upstream path is checked to see if it ends with a pattern found in that
exon's structure array. If so, the path-ﬁnding continues, otherwise the
path is rejected. Fig. 3 shows a spliced DAG and upstream consecutive
exon structure array for each exon.
To further control the number of alternatively spliced transcripts,
RCDA has the following user-selected settings. (1) NCSSN, Non-
Consensus Splice Site Number: all splice sites other than GT:AG, GC:
AG and AT:AC are considered non-consensus. If NCSSN=0, all NCSS
edges are deleted. If NCSSN=1, only one non-consensus splice site is
allowed in a composite transcript. The default is NCSSN2, where no
more than 2 NCSS are allowed. NCSSN restrictions can be selected at
two steps in the algorithm, prior to assembly or during assembly. (2)
Exon Support Number (ESN): the minimum number of input
transcripts in which an individual exon appears; e.g. if ESN=2, each
exon in a composite transcript must be supported by at least two
independent input transcripts. The default is ESN=1. (3) Open Reading
Frame Size (OSIZE): assembled splice variants must contain an ORF
with a nucleotide length equal to or greater than the speciﬁed integer.
The default is OSIZE=0 and ORF length is ignored. Given a DAG of exonvertices V including initial vertices Vi, ﬁnal vertices Vf, an empty
Pathway list P, and an empty path p, and three optional parameters ESN,
NCSSN and OSIZE, the following is the pseudocode of DAssemble.
DAssemble pseudocode:
for each vi in Vi do
DFS (vi, vi, V, p, P, ESN, NCSSN, OSIZE)
The pseudocode for the recursive DFS function:
DFS (v, V, p, P, ESN, NCSSN, OSIZE)
1. if p contains sub path in the exon structure array of v; do
2. p←p+v //elongated the path p with v
3. if support of v≥ESN and p has NCSS number≤NCSSN do
4. if v in Vf; do
5. if p has orf≥OSIZE do
6. add p to P
7. else
8. for each child of v in DAG as vc
9. DFS (vc, V, p, P, ESN, NCSSN, OSIZE)4.2. Transcript datasets
4.2.1. Complete HSA21 transcript dataset and genomic coordinates
For testing RCDA and comparison with EasyCluster and ECgene,
three transcript datasets were derived from the spliced EST, mRNA
and RefSeq transcripts mapping to human chromosome 21 (HSA21).
Sequences were retrieved, with their genomic coordinates, from the
University of California Santa Cruz (UCSC) Genome Browser (12/17/
2010; GRC37/hg19) [35]. To eliminate sequences of poor quality, the
transcripts were ﬁltered to exclude the following: intronless ESTs;
chimeric ESTs, and mRNAs (deﬁned as transcripts with b70% of the
nucleotide sequence mapping to HSA21); ESTs and intronless mRNAs
with ≥80% repeat content or those that are located entirely within an
exon of another transcript; intronless mRNAsb500 nucleotides (nt)
in length; ESTs with total lengthb100 nt; single-spliced ESTs with an
intronb25 nt; a majority of non-consensus splice sites (consensus
splice sites deﬁned as: GT:AG, GC:AG, and AT:AC) [32]; or single-
splice ESTs with at least one exonb10 nt in length or b15 nt in length
with low complexity (≥90% of the exon is a single nucleotide repeat).
ESTs and mRNAs with these features are typically unique and/or
clearly artifactual representations of a well-established gene struc-
ture. Lastly, we excluded ESTs and mRNAs with matches in multiple
genomic locations and where the best match was not HSA21. This
ﬁrst transcript set contained 23,286 sequences and is considered the
complete HSA21 transcript input. This transcript data set is used as
the test dataset to evaluate RCDA performance.4.2.2. EasyCluster HSA21 transcript dataset and genomic coordinates
To compare the performance of the RCDA clustering module,
RCluster, with that of the EasyCluster software [26], the complete
HSA21q transcript dataset was further ﬁltered according to the
EasyCluster criteria to exclude intronlessmRNAs. This second transcript
set contained 21,599 sequences and is considered the EasyCluster
transcript input. EasyCluster uses GMAP to determine genomic
coordinates of exons. Therefore, while several tools [35–38] are
available for this, we chose to use GMAP in RCDA to facilitate
comparison of RCluster results with those from EasyCluster.4.2.3. HSA21q RefSeq transcript dataset
To evaluate the performance of the RCDA assembly module,
DAssemble, we created the third HSA21 transcript dataset, composed
of all RefSeq mRNAs, as the benchmark dataset.
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RCDAwas typically run on a Dell Inspiron 9400with theWindows XP
operating system, 2.00 GHzCPU, and 2.00 GBRAM. To compare RCDA run
times with those of EasyCluster, both methods were also executed under
Linux Red Hat 4.1.2-50 with an Intel Xeon 2.66 GHz CPU and 4MB cache
size.
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